The Bladder Cancer Research Innovation Award supports investigators pursuing novel, high-risk research on bladder cancer or upper tract urothelial carcinoma to overcome key barriers and advance understanding.
Young Investigator Awards from the Bladder Cancer Advocacy Network support early-career cancer researchers studying bladder and upper tract urothelial cancer to improve understanding, treatment, and patient experience.
The 2026 BCAN Continuity Grant supports U.S. investigators whose bladder cancer research lost federal funding or narrowly missed NIH funding, helping scientifically reviewed projects continue.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
Young Investigator Awards support early-career investigators at NCCN Member Institutions, funding research in cancer biology, diagnosis, treatment, and care delivery to advance cancer care.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.